Meiying Shen
- Topics
- CAR-T cell therapy research (10 papers)SARS-CoV-2 and COVID-19 Research (6 papers)COVID-19 Clinical Research Studies (5 papers)
- Cited by
- Cancer ResearchOncologyImmunology
In The Last Decade
Meiying Shen
36 papers receiving 404 citations
Peers
Comparison fields: 5 of 66
- Molecular Biology 187
- Oncology 147
- Cancer Research 126
- Immunology 90
- Infectious Diseases 69
Countries citing papers authored by Meiying Shen
This map shows the geographic impact of Meiying Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiying Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiying Shen more than expected).
Fields of papers citing papers by Meiying Shen
This network shows the impact of papers produced by Meiying Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiying Shen. The network helps show where Meiying Shen may publish in the future.
Co-authorship network of co-authors of Meiying Shen
This figure shows the co-authorship network connecting the top 25 collaborators of Meiying Shen. A scholar is included among the top collaborators of Meiying Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meiying Shen. Meiying Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 7 | |
| 8 | 5 | |
| 9 | 2 | |
| 10 | 12 | |
| 11 | 6 | |
| 12 | 9 | |
| 13 | 29 | |
| 14 | 36 | |
| 15 | 10 | |
| 16 | 7 | |
| 17 | 42 | |
| 18 | 22 | |
| 19 | 0 | |
| 20 | 26 |
About Meiying Shen
Meiying Shen is a scholar working on Oncology, Immunology and Cancer Research, having authored 42 papers that have together received 413 indexed citations. Recurring topics across this work include CAR-T cell therapy research (10 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and COVID-19 Clinical Research Studies (5 papers). The work is most often cited by research in Cancer Research (126 citations), Oncology (147 citations) and Immunology (90 citations). Meiying Shen has collaborated with scholars based in China, Hong Kong and Japan. Frequent co-authors include Da Pang, Xiaojian Han, Aishun Jin, Weixiong Yang, Zhaojun Wu, Yuxia Chen, Tingting Li, Yu Xu, Shouping Xu and Wang Wang. Their work appears in journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.